[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100342358":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":39,"locations":50,"responsibleParty":68,"collaborators":44,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":72,"sex":78,"minAge":79,"maxAge":44,"enrollmentInfo":80,"targetDuration":44,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":93,"whyStopped":44,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Physidia","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Daily hemodialysis patients","EXPERIMENTAL","Description: End stage renal disease patients starting daily hemodialysis treatment.\n\nInterventions: Delivery of a connected pedometer \u002F accelerometer and Quality Of Life and Restless Leg Syndrome questionnaires.",[13],"Other: Delivery of a connected pedometer \u002F accelerometer",{"label":15,"type":16,"description":17,"interventionNames":18},"Conventional hemodialysis patients","ACTIVE_COMPARATOR","Description: End stage renal disease patients currently treated by conventional hemodialysis or starting conventional hemodialysis treatment.\n\nInterventions: Delivery of a connected pedometer \u002F accelerometer and Quality Of Life and Restless Leg Syndrome questionnaires.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"OTHER","Delivery of a connected pedometer \u002F accelerometer","Delivery of a connected pedometer \u002F accelerometer that the patient will be asked to wear at least 7 consecutive days \u002F month.\n\nQuality of life and leg restless syndrome questionnaires (auto questionnaire) completed by the patients every 3 months",[15,9],[26],"Quality of life and restless leg syndrome questionnaires",[28,32,36],{"name":29,"affiliation":30,"role":31},"Natalia Target, MD","Centre Hospitalier La Roche sur Yon - France","PRINCIPAL_INVESTIGATOR",{"name":33,"affiliation":34,"role":35},"Cécile Courivaud, MD","CHRU Jean Minjoz, Besançon, France","STUDY_CHAIR",{"name":37,"affiliation":38,"role":35},"Pierre Antoine Michel, MD","Hôpital Tenon APHP, Paris, France",[40,46],{"name":41,"role":42,"phone":43,"phoneExt":44,"email":45},"Michel Thomas, PhD","CONTACT","+33 (0)6 74 28 71 99",null,"michel.thomas@physidia.fr",{"name":47,"role":42,"phone":48,"phoneExt":44,"email":49},"Bernadette Darne, MD","+33 (0) 1 39 62 15 27","bernadette.darne@monitoring-force.fr",[51],{"facility":52,"status":53,"city":54,"state":44,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"Centre Hospitalier","RECRUITING","La Roche-sur-Yon","85000","France","FR",{"type":59,"coordinates":60},"Point",[61,62],-1.42757,46.66974,{"lat":62,"lon":61},[65],{"name":29,"role":42,"phone":66,"phoneExt":44,"email":67},"+33 (0) 2 51 44 61 65","natalia.target@chd-vendee.fr",{"type":69,"investigatorFullName":44,"investigatorTitle":44,"investigatorAffiliation":44,"oldNameTitle":44,"oldOrganization":44},"SPONSOR","100342358","comparison-of-daily-home-hemodialysis-hd-with-conventional-in-center-hd-in-terms-of-patients-quality-of-life-and-clinical-outcomes-100342358",false,"NCT03737578","Comparison of Daily Home Hemodialysis (HD) With Conventional in Center HD in Terms of Patients Quality of Life and Clinical Outcomes","Efficacy of Daily Hemodialysis Compared With in Center Hemodialysis 3 Times Per Week","SeCoIA","Inclusion Criteria:\n\n1. Male or female aged 18 years or over\n2. Patient who dated and signed the consent form\n3. Patient (s) affiliated to a Social Security scheme\n4. Interventional arm: patient who begins or will begin daily hemodialysis training (5, 6 or 7 times per week) at home.\n5. Comparator arm: prevalent or incident patient treated by conventional hemodialysis (3 times per week) and fitting with the matching criteria of an interventional patient included in the center\n\nExclusion Criteria:\n\n1. Patient with needs any help to walk (wheelchair, crutch, walker, cane ...)\n2. Patient with active neoplasia;\n3. Patient with predicted life expectancy of less than one year;\n4. Patient with significant reading or writing difficulties;\n5. Patient participating in a clinical trial or other interventional study; 6. Patient with history of mental instability, major cognitive impairment in the previous 5 years, or major psychiatric condition not adequately controlled or stable under pharmacological treatment","ALL","18 Years",{"count":81,"type":82},160,"ESTIMATED","INTERVENTIONAL",[85],"NA","The objective of this study is to describe the characteristics of patients on daily home hemodialysis and to confirm in real practice in France the effectiveness shown in studies, mainly American, both in terms of clinical outcomes and quality of life. Due to the few studies available in this population, the focus will be particularly on physical activity.",[88],"End Stage Renal Disease",[90,91,92],"Home hemodialysis","Daily hemodialysis","Frequent hemodialysis","UNKNOWN","2020-03-09",{"date":96,"type":97},"2020-03-10","ACTUAL",{"date":99,"type":97},"2018-06-27",{"date":101,"type":82},"2021-06",{"name":5,"class":6},1]